Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03151148
What this trial is testing

Targeted Microbiome Transplant in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Study completedNCT06345404
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD

Who this might be right for
Atopic Dermatitis
Corvus Pharmaceuticals, Inc. 82
Large-scale testing (Phase 3)Not Yet RecruitingNCT07479615
What this trial is testing

Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopic Eczema
Shanghai Mabgeek Biotech.Co.Ltd 498
Not applicableLooking for participantsNCT05819463
What this trial is testing

Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

Who this might be right for
Atopic Dermatitis
Swiss Society of Dermatology and Venereology 700
Testing effectiveness (Phase 2)Ended earlyNCT05048056
What this trial is testing

Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Akesobio Australia Pty Ltd 79
Testing effectiveness (Phase 2)Active Not RecruitingNCT06176040
What this trial is testing

TAVO101 in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Tavotek Biotherapeutics 20
Not applicableEnded earlyNCT01286220
What this trial is testing

Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
University of Texas Southwestern Medical Center 27
Testing effectiveness (Phase 2)Looking for participantsNCT07660835
What this trial is testing

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis

Who this might be right for
Moderate-to-Severe Atopic Dermatitis
Galderma R&D 35
Testing effectiveness (Phase 2)Study completedNCT06116565
What this trial is testing

CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 263
Testing effectiveness (Phase 2)Study completedNCT06283550
What this trial is testing

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Who this might be right for
Chronic Hand Eczema
Innovaderm Research Inc. 82
Very early researchStudy completedNCT05891119
What this trial is testing

Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 21
Testing effectiveness (Phase 2)Study completedNCT04598269
What this trial is testing

Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 50
Large-scale testing (Phase 3)Looking for participantsNCT06807281
What this trial is testing

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Who this might be right for
Atopic Dermatitis
Pfizer 500
Early research (Phase 1)Study completedNCT03514511
What this trial is testing

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 47
Early research (Phase 1)Ended earlyNCT05177328
What this trial is testing

Targeted Investigation of Microbiome Elimination

Who this might be right for
Atopic Dermatitis
National Institute of Allergy and Infectious Diseases (NIAID) 21
Testing effectiveness (Phase 2)Ended earlyNCT03817190
What this trial is testing

Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
DS Biopharma 219
Large-scale testing (Phase 3)Study completedNCT04626297
What this trial is testing

Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 254
Testing effectiveness (Phase 2)Study completedNCT04800315
What this trial is testing

Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, AtopicEczema
Celgene 221
Large-scale testing (Phase 3)Study completedNCT06181435
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Who this might be right for
Dermatitis Atopic
Sanofi 589
Large-scale testing (Phase 3)Looking for participantsNCT07355075
What this trial is testing

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

Who this might be right for
Eczema Atopic DermatitisEczemaAtopic Dermatitis
Turn Therapeutics 190
Next Page